Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for VERWENDUNG VON MIGALOSTAT ZUR VERRINGERUNG DES RISIKOS DES ZEREBROVASKULÄREN EREIGNISSES BEI PATIENTEN MIT FABRY-KRANKHEIT
Details for 2020708283
Up to date per 10.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2020708283
Title / Product Name
VERWENDUNG VON MIGALOSTAT ZUR VERRINGERUNG DES RISIKOS DES ZEREBROVASKULÄREN EREIGNISSES BEI PATIENTEN MIT FABRY-KRANKHEIT
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2020708283
EP Publication Number
3914247
E-Number
1741131
Language
EN
PCT Number
US20014531
Publication Date
01.12.2021 A
13.11.2024 B1
Registration Date
13.11.2024
AT Publication Date
15.12.2024
Application Date
22.01.2020
Registration Number
-
Priorities
22.01.2019
US
201962795524 P
IPC
A61K 31/445 20060101AFI20200803BHEP
Maximum Duration of Protection
22.01.2040
Owner
Amicus Therapeutics, Inc.
3675 Market Street
Philadelphia, PA 19104
US
Representative
No representatives present
Inventor
SKUBAN, Nina
Amicus Therapeutics, Inc. 1 Cedar Brook Drive
Cranbury, New Jersey 08512
US
LAGAST, Hjalmar
Amicus Therapeutics, Inc. 1 Cedar Brook Drive
Cranbury, New Jersey 08512
US
Information about Fees
Click here to load the fees